Here’s something that should fundamentally change how we think about autism and cannabis: autistic children have significantly reduced plasma levels of endocannabinoids. […]
It’s difficult to admit this—especially to the readers of High Times—but for most of my life, I flat-out hated the hippies. That’s […]
Talk a walk through the hall of fame with our look back at past Leafly Strain of the Year winners. This year’s […]
The pharmacological difference between natural THC and synthetic cannabinoids like K2 is the difference between a partial agonist and a full agonist. […]
Major breakthroughs in dry herb vape tech have pushed performance to new levels of potency and power. At-home vaporists are experiencing stronger, […]
More than a decade ago, my fitness coach and friend, Jenny, called me in distress. She had just been attacked and severely […]
Here’s the reality that gets buried under every sensationalized headline about “marijuana-induced madness”: the baseline annual incidence of psychotic disorders in the […]
The head grower at a 100,000-square-foot facility was getting hammered over flat yields. Investors wanted “efficiency,” the CEO wanted a silver bullet, […]
Time seems to go by so fast. In reality, it moves no faster—or slower—than ever, but there’s a very specific feeling, distinctive […]
The New York Times has published a poorly researched, misleading op-ed on the cannabis industry and the effects of legalization. Read our […]